The United States Trypanosoma cruzi Infection Study: evidence for vector‐borne transmission of the parasite that causes Chagas disease among United States blood donors
- 8 March 2012
- journal article
- Published by Wiley in Transfusion
- Vol. 52 (9), 1922-1930
- https://doi.org/10.1111/j.1537-2995.2012.03581.x
Abstract
Screening US blood donors for Trypanosoma cruzi infection is identifying autochthonous, chronic infections. Two donors in Mississippi were identified through screening and investigated as probable domestically acquired vector-borne infections, and the US T. cruzi Infection Study was conducted to evaluate the burden of and describe putative risk factors for vector-borne infection in the United States. Blood donors who tested enzyme-linked immunosorbent assay repeat reactive and positive by radioimmunoprecipitation assay, and whose mode of infection could not be identified, were evaluated with a questionnaire to identify possible sources of infection and by additional serologic and hemoculture testing for T. cruzi infection. Of 54 eligible donors, 37 (69%) enrolled in the study. Fifteen (41%) enrollees had four or more positive serologic tests and were considered positive for T. cruzi infection; one was hemoculture positive. Of the 15, three (20%) donors had visited a rural area of an endemic country, although none had stayed for 2 or more weeks. All had lived in a state with documented T. cruzi vector(s) or infected mammalian reservoir(s), 13 (87%) reported outdoor leisure or work activities, and 11 (73%) reported seeing wild reservoir animals on their property. This report adds 16 cases, including one from the Mississippi investigation, of chronic T. cruzi infection presumably acquired via vector-borne transmission in the United States to the previously reported seven cases. The estimated prevalence of autochthonous infections based on this study is 1 in 354,000 donors. Determining US foci of vector-borne transmission is needed to better assess risk for infection.Keywords
This publication has 24 references indexed in Scilit:
- Trypanosoma cruzi and Chagas' Disease in the United StatesClinical Microbiology Reviews, 2011
- Chagas diseaseThe Lancet, 2010
- Biogeography andTrypanosoma cruziInfection Prevalence of Chagas Disease Vectors in Texas, USAVector-Borne and Zoonotic Diseases, 2009
- Chagas disease and the US blood supplyCurrent Opinion in Infectious Diseases, 2008
- Autochthonous Transmission ofTrypanosoma cruzi, LouisianaEmerging Infectious Diseases, 2007
- Chagas' disease: application of TESA-blot in inconclusive sera from a Brazilian blood bankVox Sanguinis, 2004
- Serodiagnosis of Chronic and Acute Chagas' Disease with Trypanosoma cruzi Recombinant Proteins: Results of a Collaborative Study in Six Latin American CountriesJournal of Clinical Microbiology, 2004
- Evaluation of the Performance of Brazilian Blood Banks in Testing for Chagas' DiseaseVox Sanguinis, 1998
- Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II. Evaluation of a supplemental enzyme immunoassay and radioimmunoprecipitation assay for confirmation of seroreactivityTransfusion, 1995
- Increased Specificity of Serodiagnosis of Chagas' Disease by Detection of Antibody to the 72- and 90-Kilodalton Glycoproteins of Trypanosoma cruziThe Journal of Infectious Diseases, 1987